The research team will conduct an investigation into an in vitro tissue culture model known as "Cancer Organoids," which has been generously supplied by Weill Cornell Medicine, one of the four esteemed Cancer Model Development Centers in the United States. Their primary focus will be on the development of tools and methodologies encompassing microtissue culture, mechanical characterization, high-resolution 3D microscopic imaging, and drug screening.